March 26th, 2019
Harvard researchers’ immune-silent stem cell technology licensed to Sana Biotechnology
Developed through Harvard’s Blavatnik Biomedical Accelerator, innovations could lead to novel cell therapies to treat disease
News All News
Press Contact: Kirsten Mabry | (617) 495-4157
Tag: Blavatnik Biomedical Accelerator
March 26th, 2019
Developed through Harvard’s Blavatnik Biomedical Accelerator, innovations could lead to novel cell therapies to treat disease
February 11th, 2019
Injectable sponge-like gel enhances the quantity and quality of T-cells
February 8th, 2019
New advances selectively suppress damaged cells, allowing for transplants without chemotherapy or radiation
February 7th, 2019
FUSION symposium brings two spheres together to lend insights to action
May 31st, 2018
Six outstanding HBS alumni will work with inventors from the Harvard community, advance commercialization of life-science technologies